| 1 day | -100.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
David Marantz
CEO | Chief Executive Officer | - | - |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Marantz
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/28/23 | Sell | Chief Executive Officer | 400,000 | 2.6910% | ||
| 9/28/23 | Other | Chief Executive Officer | 0 | 0.0000% | ||
| 5/30/23 | Other | Founder | 0 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -100.00% | -100.00% | - | - | 25 | ||
| -14.90% | -16.49% | -47.70% | -12.18% | 16.76B | ||
| -2.56% | +0.57% | -10.41% | +0.35% | 7.22B | ||
| -0.17% | +10.36% | +5.00% | +12.05% | 7.33B | ||
| -5.20% | -8.68% | -52.68% | -41.81% | 5.94B | ||
| +1.68% | +8.48% | +9.42% | -15.21% | 4.84B | ||
| +0.50% | -2.95% | -37.55% | -47.23% | 4.28B | ||
| +0.14% | +2.66% | +14.65% | -18.70% | 3.56B | ||
| -1.50% | +4.72% | -21.73% | +32.92% | 3.34B | ||
| -0.42% | +0.32% | -12.82% | -30.36% | 3.3B | ||
| Average | -12.25% | +1.81% | -17.09% | -13.35% | 6B | |
| Weighted average by Cap. | -5.26% | +0.65% | -23.49% | -12.27% |
Employees
-
Sector
Drug Retailers
















